Skip to content

← All news

Markets

Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress

1 source ·1 article ·Sep 7, 05:53 UTC Summit Therapeutics

Covered by 1 outlet

All coverage · 1 article

Yahoo Finance News ·Sep 7, 05:53 UTC

Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress